Selling powdered milk might not sound like an exciting business, but don't say that around executives at Mead Johnson and Abbott Labs . Both companies sport sizable consumer nutrition businesses, and some recent regulation changes in Hong Kong made headlines given their potential impact on powdered milk (e.g., infant formula) sales in the region. Follow along in the video below as Brenton Flynn and Max Macaluso discuss whether this is news that long-term investors should be concerned about, or noise they can ignore.
For some Abbott Labs shareholders, the new year brought with it a new company called AbbVie. Formerly Abbott's branded pharmaceuticals business, shares of the new stock were distributed to investors on Jan. 2. To help investors better understand the situation, The Fool has created a brand new premium report on both stocks. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this report by clicking here now.
The article News or Noise: Chinese Milk, Mead Johnson, and Abbott Labs originally appeared on Fool.com.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.